PMC:7035340 / 7261-7503
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 235 | 122-130 | Species | denotes | patients | Tax:9606 |
| 236 | 218-226 | Species | denotes | patients | Tax:9606 |
| 237 | 232-241 | Species | denotes | 2019-nCoV | Tax:2697049 |
| 238 | 118-121 | Disease | denotes | NCP | MESH:C000657245 |
| 239 | 203-217 | Disease | denotes | critically ill | MESH:D016638 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T42 | 152-167 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T35 | 0-242 | Sentence | denotes | However, our clinical experience and available descriptive data from the therapeutic process of the first 15 critical NCP patients are prone to support corticosteroids treatment for specific subgroup of critically ill patients with 2019-nCoV. |